多位点不合的非清髓异基因外周血造血干细胞移植治疗慢性粒细胞性白血病1例
出处
《临床军医杂志》
CAS
2004年第6期128-129,共2页
Clinical Journal of Medical Officers
参考文献12
-
1[1]Slavin S,Nagler A, Naparstek E,et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases[J].Blood,1998,3(1):756. 被引量：1
-
2[2]Brown R A, Adkins L T, Goodnough L T,et al. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies[J].J Clin Oncol,1997,15(9):3 067～3 074 . 被引量：1
-
3[3]Roy A J, Jaffe N, Djerassi I. Prophylatic platelet transfusions in children with acute leukemia: a dose response study[J].Transfusion, 1973,13:283. 被引量：1
-
4达万明 裴雪涛.外周血干细胞移植[M].北京:人民卫生出版社,2001.112-113,118. 被引量：2
-
5崔钊,牛亚明.造血干细胞移植在非霍奇金淋巴瘤治疗中的应用[J].国外医学（肿瘤学分册）,1998,25(5):312-314. 被引量：4
-
6[6]Slavin S,Nagler A, Naparstek E,et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases[J]. Blood,1998,91(3):757-763. 被引量：1
-
7[7]Sykes M, Saches D H, Spitzer T R. Mixed chimerism followed by DLI for lymphohematoietic GVHreactions without GVHD: from animal models to patients[J]. Hematology,1999,(American Society of Hematology Education Program Book):405. 被引量：1
-
8艾辉胜.非清髓异基因造血干细胞移植——造血干细胞移植的新方向[J].解放军医学杂志,2001,26(1):1-4. 被引量：11
-
9[9]Champlin R. Nonmyeloablative chemotherapy with allogeneic hematopoietic transplantation as adoptive immunotherapy for malignancies[A]. In: Schechter GP, Hoffman R, Schrier SL(eds). Hematology[M]. Washington:The ASH education program book,1999.405-412. 被引量：1
-
10[10]To L B, Haylock D N, Simmons P J,et al.The biology and clinica uses of blood stem cells[J]. Blood,1997,89(7):2 233 被引量：1
二级参考文献12
-
1[1]Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.Blood,1998,91:756 被引量：1
-
2[2]Champlin R, Khouri I, Kornblau S et al. Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy. Curr Opin Oncol, 1999, 11(2): 87 被引量：1
-
3[3]Storb R, Zaucha YC, Beeg HJ et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4IG and 100cGY total body irradiation befor and pharmacologic immunosupression after marrow transplant. Blood, 1999,94(7):2523 被引量：1
-
4[4]Sykes M, Saches DH, Spitzer TR. Mixed chimerism followed by DLI for lymphohematoietic GVH reactions without GVHD: from animal models to patients. Hematology, 1999,(American Society of Hematology Education Program Book):405 被引量：1
-
5[5]Khouri L, Keating M, Korbling M et al. Transplant-lite: induction of gfaft-versus-maliganancy using fludabine-based nonblative chenmotherapy and allogenetic blood progenitor-cell transplantation as treatment for lymphoid maligancies. J Clin Oncol, 1998,16(8):2817 被引量：1
-
6[6]McSweeney P, Storb R.Establishing mixed minimally myelosuppressive conditioning : preclinical and clinical studies.Hematology, 1999,396 被引量：1
-
7[7]Shimoni A, Anderlini B, Estey E et al. Allogeneic transplantation for leukemia in patients older than 60 years: age should not exclude treatment with nonmyeloablative regimen. Blood, 1999,94(suppl 1):710 被引量：1
-
8[8]Giralt S,Estey E, Albiter M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy .Blood,1997,89(12):4531 被引量：1
-
9[9]Gomez Almaguer G, Ruiz Arguelles GJ, Ruiz Arguelles A et al. Hematopoietic stem cell allograft using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases. Bone Marrow Transpl, 2000,25:131 被引量：1
-
10[10] Amrolia P, Gaspar HB, Hassan A et al. Nonmyeloablative stem cell transplatation for congenital immunodeficiencies. Blood, 2000,96(4):1239 被引量：1
共引文献13
-
1李俭杰,张毅,张明伟,侯春梅,吴英,毛宁,艾辉胜.小鼠H-2半相合非清髓同种异基因造血干细胞移植模型的建立及其相关研究[J].中国实验血液学杂志,2004,12(5):655-660. 被引量：3
-
2李新,孙万军,原野,毛宁,艾辉胜.小鼠H-2单倍相合非清髓骨髓移植后细胞因子表达的动态研究[J].中国实验血液学杂志,2005,13(4):687-691. 被引量：3
-
3吴敏媛,朱光华,周翾.清髓和非清髓造血干细胞移植[J].中国实用儿科杂志,2005,20(11):651-653. 被引量：1
-
4黄雅静,孙琪云,刘丽辉,胡恺勋,范传波,边莉,郭梅,艾辉胜.猕猴单倍体相合外周血造血干细胞移植后多种细胞因子mRNA表达的动态分析[J].中国实验血液学杂志,2006,14(3):571-576. 被引量：1
-
5马庆,范华骅,范慧珠,郑滨,袁纪军.非程控-80℃冷冻保存自体外周血干细胞移植的临床研究[J].中国输血杂志,2001,14(2):94-95. 被引量：6
-
6肖秀斌,艾辉胜.非清髓异基因造血干细胞移植动物实验研究进展[J].实验动物科学与管理,2002,19(1):29-31.
-
7陈燕琴,丰明星,韩娜,李艳丽,赵伟伟.一例非清髓造血干细胞移植治疗乳腺癌继发高危急性白血病患者的护理[J].中华现代护理杂志,2014,20(29):3771-3773. 被引量：1
-
8王俊可,韩阿如娜,王丽梅,余祖胤,徐铁柱,杨超,善亚君,崔宇,柳晓兰,从玉文.rhG-CSF大剂量单次给药对非清髓骨髓移植小鼠造血功能重建的影响[J].中华放射医学与防护杂志,2015,35(7):501-504. 被引量：1
-
9王晓娜,梁雨蒙,邓磊,王路,王一,黄雅静,刘铁强,左洪莉,胡锴勋,乔建辉,孙琪云,郭梅,艾辉胜,余长林.H-2单倍体相合小鼠双供体造血干细胞移植模型的建立[J].中国实验血液学杂志,2017,25(2):522-529. 被引量：1
-
10李大鹏,杜遵民,徐学芳,任红,孙军山.急性髓系白血病外周造血干细胞采集及移植(附1例报告)[J].实用医药杂志,2002,19(8):583-584.
-
1马丽辉,李宝平,刘卓拉,乔振.异基因造血干细胞移植治疗晚期胸部肿瘤[J].中国肿瘤临床,2007,34(17):1012-1013. 被引量：1
-
2李仝,艾辉胜,黎燕.非清髓性异基因造血干细胞移植研究进展[J].癌症,2001,20(10):1112-1114. 被引量：1
-
3余长林,艾辉胜,赵春华,王丹红,乔建辉,郭梅,张石,孙万军,姚波.非清髓性异基因外周血造血干细胞移植治疗慢性白血病七例报告[J].中华器官移植杂志,2003,24(5):261-263. 被引量：2
-
4艾辉胜,余长林,王丹红,郭梅,乔建辉,时葆赋,孙万军,张石,孙琪云,姚波.非清髓异基因外周血造血干细胞移植治疗血液病的临床观察[J].中华血液学杂志,2003,24(2):86-89. 被引量：13
-
5张燕,王季石,孙志强,王椿.非清髓异基因外周血造血干细胞移植治疗一例慢性粒细胞白血病[J].贵州医药,2006,30(4):323-324.
-
6陈学良.非清髓性异基因造血干细胞移植的创新与展望[J].肿瘤学杂志,2004,10(6):375-377. 被引量：1
-
7耿建,陈龙邦.非清髓性异基因干细胞移植治疗实体瘤的研究进展[J].医学研究生学报,2005,18(2):178-181.
-
8郭宏锋,乔振华,苏丽萍,葛晓燕,姜波,朱秋娟,李容萍.非清髓性异基因外周血造血干细胞移植[J].中华器官移植杂志,2003,24(5):264-266. 被引量：2
-
9朱海燕,达万明,张伯龙,高春记,韩晓萍,吴晓雄,赵瑜,靖域,薄剑,王书红.非清髓异基因外周血造血干细胞移植治疗慢性粒细胞白血病[J].临床血液学杂志,2004,17(5):249-251. 被引量：3
-
10张丽,张东华,黄伟,李登举,孟凡凯,周剑锋,黄梅,刘文励.双次造血干细胞移植治疗多发性骨髓瘤一例临床分析[J].临床内科杂志,2006,23(6):428-429.
